Current Treatment Options in Oncology

eISSN: 1534-6277pISSN: 1527-2729

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

CiteScore
7
Impact Factor
< 5
SJR
Q1Oncology
SNIP
1.4

Journal Specifications

Overview
  • Publisher
    SPRINGER
  • Language
    English
  • Frequency
    Monthly
General Details
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

Meets Top Publisher Standards: Essential for leading journals like Elsevier.
Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn more 3000+ graphical abstracts produced with 4.8/5 customer rating

Topics Covered

Cancer
Neuroendocrine tumors
Doxorubicin
Immunotherapy
Surgical resection
Breast cancer
Overall survival
Prime time
Cardiotoxicity
Proton therapy
Osteosarcoma
Prostate cancer
Mycosis fungoides
Cardiac metabolism
Observational study
Immune checkpoint inhibitors
Triple-negative breast cancer
Oncology
Toxicity
Doxorubicin cardiotoxicity

Recently Published Papers

Year-wise Publication

FAQs

Since when has Current Treatment Options in Oncology been publishing? Faqs

The Current Treatment Options in Oncology has been publishing since 1999 till date.

How frequently is the Current Treatment Options in Oncology published? Faqs

Current Treatment Options in Oncology is published Monthly.

Who is the publisher of Current Treatment Options in Oncology? Faqs

The publisher of Current Treatment Options in Oncology is SPRINGER.

How can I view the journal metrics of Current Treatment Options in Oncology on editage? Faqs

For the Current Treatment Options in Oncology metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Current Treatment Options in Oncology? Faqs

The eISSN number is 1534-6277 and pISSN number is 1527-2729 for Current Treatment Options in Oncology.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Cancer, Neuroendocrine tumors, Doxorubicin, Immunotherapy, Surgical resection, Breast cancer, Overall survival, Prime time, Cardiotoxicity, Proton therapy, Osteosarcoma, Prostate cancer, Mycosis fungoides, Cardiac metabolism, Observational study, Immune checkpoint inhibitors, Triple-negative breast cancer, Oncology, Toxicity, Doxorubicin cardiotoxicity.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.